Instrument Inactif

Communiqués Avivagen Inc Toronto S.E.

Actions

VIV

CA05382F1036

Pêche et agriculture

Communiqués

24/04/24	Avivagen Makes Voluntary Assignment into Bankruptcy Under the BIA	NE
06/04/21	Avivagen Discusses Significant Purchase Orders for OxC-beta(TM) Livestock with The Stock Day Podcast	NE
23/07/20	Avivagen: The OxC-beta(TM) Technology Is A True Game Changer	NE
02/10/19	Avivagen Inc. CEO, Kym Anthony, Joins The Stock Day Podcast to Discuss Their Expansion Strategy	NE
01/05/18	Avivagen Announces its Attendance at the Bloom Burton & Co. Healthcare Investor Conference	GL
13/04/18	Avivagen Announces the Issuance of Stock Options	GL
26/03/18	Avivagen Announces Continued Growth and Adoption in the Commercial Use of OxC-beta™ Livestock in the Philippines	GL
19/03/18	Cesar Millan’s Highly Recommended Vivamune™ Scheduled for Global Pet Expo Debut	GL
27/02/18	Avivagen Announces CEO Update and January 31, 2018 Financial First Quarter Results	GL
15/01/18	Avivagen Announces Positive Results from Swine Trial	GL
08/01/18	Avivagen Announces Positive Results from Dairy Cattle Trial	GL
22/12/17	Avivagen Inc. Announces the Granting of Options	GL
20/12/17	Avivagen Inc. Announces Results for Fiscal Year Ending October 31, 2017	GL
30/11/17	IIROC Trade Resumption - Avivagen Inc.	NE
30/11/17	Avivagen Announces Closing of Private Placement Totaling $4 million	GL
30/11/17	IIROC Trade Halt - Avivagen Inc.	NE
22/11/17	Avivagen Announces the Appointment of Mr. Aubrey Dan to the Board of Directors	GL
23/10/17	Cesar Millan helps Avivagen Relaunch Vivamune™ Health Chews in U.S.	GL
07/09/17	Avivagen Announces Chief Executive Officer and Issuance of Third Quarter Results	GL
16/08/17	Avivagen Announces Scale Up of Commercial Roll Out for OxC-beta™ Livestock in the Philippines	GL
10/07/17	Cesar Millan to Endorse Avivagen’s Companion Animal Health Product Vivimune Health Chews	GL
26/05/17	Avivagen Announces Third Purchase Order of OxC-Beta™ Livestock from UNAHCO Inc.	GL